DK0700294T3 - Injektionsopløsning til intramuskulær og subkutan indgivelse i dyr - Google Patents
Injektionsopløsning til intramuskulær og subkutan indgivelse i dyrInfo
- Publication number
- DK0700294T3 DK0700294T3 DK94918790T DK94918790T DK0700294T3 DK 0700294 T3 DK0700294 T3 DK 0700294T3 DK 94918790 T DK94918790 T DK 94918790T DK 94918790 T DK94918790 T DK 94918790T DK 0700294 T3 DK0700294 T3 DK 0700294T3
- Authority
- DK
- Denmark
- Prior art keywords
- animals
- intramuscular
- subcutaneous administration
- solution
- injection solution
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title abstract 2
- 238000007918 intramuscular administration Methods 0.000 title abstract 2
- 238000002347 injection Methods 0.000 title 1
- 239000007924 injection Substances 0.000 title 1
- 239000000243 solution Substances 0.000 title 1
- 238000007920 subcutaneous administration Methods 0.000 title 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 abstract 1
- 239000004100 Oxytetracycline Substances 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 239000003125 aqueous solvent Substances 0.000 abstract 1
- 229960003722 doxycycline Drugs 0.000 abstract 1
- XQTWDDCIUJNLTR-CVHRZJFOSA-N doxycycline monohydrate Chemical compound O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O XQTWDDCIUJNLTR-CVHRZJFOSA-N 0.000 abstract 1
- 229940102223 injectable solution Drugs 0.000 abstract 1
- 150000007529 inorganic bases Chemical class 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000007530 organic bases Chemical class 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 229960000625 oxytetracycline Drugs 0.000 abstract 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 abstract 1
- 235000019366 oxytetracycline Nutrition 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP93108460A EP0626171A1 (de) | 1993-05-26 | 1993-05-26 | Injektionslösung für die intravenöse oder intramuskuläre Verabreichung an Tiere |
| PCT/EP1994/001696 WO1994027611A1 (de) | 1993-05-26 | 1994-05-25 | Injektionslösung für die intramuskuläre und subkutane verabreichung an tiere |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0700294T3 true DK0700294T3 (da) | 1999-03-29 |
Family
ID=8212938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94918790T DK0700294T3 (da) | 1993-05-26 | 1994-05-25 | Injektionsopløsning til intramuskulær og subkutan indgivelse i dyr |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5753636A (da) |
| EP (2) | EP0626171A1 (da) |
| AT (1) | ATE169221T1 (da) |
| AU (1) | AU675553B2 (da) |
| CA (1) | CA2163772A1 (da) |
| DE (1) | DE59406622D1 (da) |
| DK (1) | DK0700294T3 (da) |
| ES (1) | ES2124414T3 (da) |
| NZ (1) | NZ267618A (da) |
| WO (1) | WO1994027611A1 (da) |
| ZA (1) | ZA943682B (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5773422A (en) * | 1996-01-29 | 1998-06-30 | Komer; Gene | Avermectin formulation |
| DE19641437A1 (de) | 1996-10-08 | 1998-04-09 | Basf Ag | 1,3-Bis-(N-lactamyl)propane und deren pharmazeutische und kosmetische Verwendung |
| GB2331458B (en) * | 1997-11-21 | 2002-07-31 | Gursharan Singh Moonga | Solubilising systems for difficult pharmaceutical actives for preparing concentrated stable solutions for encapsulation into soft gelatine |
| US6017948A (en) * | 1998-10-30 | 2000-01-25 | Supergen, Inc. | Water-miscible pharmaceutical compositions |
| ES2315123B1 (es) * | 2006-09-25 | 2009-12-30 | Divasa-Farmavic, S.A. | Composiciones farmaceuticas estables de tetraciclinas en solucion, procedimiento para su obtencion y sus usos. |
| CN111035614B (zh) * | 2019-12-20 | 2024-02-02 | 北京喜禽药业有限公司 | 一种高含量土霉素注射液及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2644782A (en) * | 1949-09-08 | 1953-07-07 | American Cyanamid Co | Aureomycin for injection |
| US2644783A (en) * | 1949-09-08 | 1953-07-07 | American Cyanamid Co | Parenteral aureomycin in anhydrous form |
| US3128227A (en) * | 1954-06-17 | 1964-04-07 | American Cyanamid Co | Antibiotic intramuscular composition |
| NL6607516A (da) * | 1966-05-31 | 1967-12-01 | ||
| US4018889A (en) * | 1976-01-02 | 1977-04-19 | Pfizer Inc. | Oxytetracycline compositions |
| US4259331A (en) * | 1979-04-16 | 1981-03-31 | Pfizer Inc. | Oxytetracycline compositions |
| IE74244B1 (en) * | 1985-10-01 | 1997-07-16 | Bimeda Res Dev Ltd | A process for preparing an antibiotic composition |
-
1993
- 1993-05-26 EP EP93108460A patent/EP0626171A1/de not_active Withdrawn
-
1994
- 1994-05-25 DE DE59406622T patent/DE59406622D1/de not_active Expired - Fee Related
- 1994-05-25 WO PCT/EP1994/001696 patent/WO1994027611A1/de not_active Ceased
- 1994-05-25 US US08/553,455 patent/US5753636A/en not_active Expired - Fee Related
- 1994-05-25 CA CA002163772A patent/CA2163772A1/en not_active Abandoned
- 1994-05-25 NZ NZ267618A patent/NZ267618A/en unknown
- 1994-05-25 AU AU69968/94A patent/AU675553B2/en not_active Ceased
- 1994-05-25 EP EP94918790A patent/EP0700294B1/de not_active Expired - Lifetime
- 1994-05-25 AT AT94918790T patent/ATE169221T1/de not_active IP Right Cessation
- 1994-05-25 ES ES94918790T patent/ES2124414T3/es not_active Expired - Lifetime
- 1994-05-25 DK DK94918790T patent/DK0700294T3/da active
- 1994-05-26 ZA ZA943682A patent/ZA943682B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0700294B1 (de) | 1998-08-05 |
| AU6996894A (en) | 1994-12-20 |
| WO1994027611A1 (de) | 1994-12-08 |
| ZA943682B (en) | 1995-01-24 |
| NZ267618A (en) | 1997-03-24 |
| US5753636A (en) | 1998-05-19 |
| DE59406622D1 (de) | 1998-09-10 |
| ES2124414T3 (es) | 1999-02-01 |
| ATE169221T1 (de) | 1998-08-15 |
| EP0626171A1 (de) | 1994-11-30 |
| CA2163772A1 (en) | 1994-12-08 |
| EP0700294A1 (de) | 1996-03-13 |
| AU675553B2 (en) | 1997-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0483667T3 (da) | Cykliske iminoderivater, lægemidler indholdende disse forbindelser og fremgangsmåde til fremstilling deraf | |
| DK0496378T3 (da) | Biphenylderivater, lægemidler indeholdende disse forbindelser og fremgangsmåder til deres fremstilling | |
| HUT67009A (en) | Truncated forms of the hepatocyte growth factor (hgf) receptor pharmaceutical compositions containing them and process for production of them | |
| BR9707317A (pt) | Processo para fazer uma composição de resina termofixa espessada | |
| ZA934290B (en) | Stabilizing compositions and methods for stabilizing subterranean formations | |
| DE60329210D1 (en) | Camptothecin-carboxylat-formulierungen | |
| ES2120992T3 (es) | Derivados de 1-metilcarbapenemo, su preparacion y su uso como antibioticos. | |
| ES2124414T3 (es) | Solucion inyectable destinada a la administracion intramuscular y subcutanea en animales. | |
| NO179833C (no) | Organiske cerium(IV)-forbindelser, fremgangsmåte for fremstilling derav og opplösning, filmdannende blanding og hydrokarbonbrennstoff omfattende slike | |
| DE59711504D1 (de) | Verfahren zur herstellung von metallkomplexcarbonsäureamiden | |
| DE59602236D1 (de) | Verfahren zur Herstellung von Ascorbinsäure | |
| DE3854266D1 (de) | Verfahren zur Modifizierung eines Molekularsiebes. | |
| DE59409816D1 (de) | Amorphe monosphärische Formen von Insulinderivaten | |
| ATE104975T1 (de) | Verfahren zur herstellung von imidazol-derivaten. | |
| DE69223262D1 (de) | Benzimidazolderivate, verfahren zur herstellung, zwischenprodukte, und diese als aktive bestandteile enthaltende antiemetische substanzen | |
| KR840009032A (ko) | 동물류 주사용 옥시테트라사이클린 수용액류와 그 제조방법 | |
| UA18708A (uk) | Спосіб кислотhої обробки пласта | |
| ATE319785T1 (de) | Verfahren zur herstellung von farbmitteln | |
| DE60011473D1 (de) | Diazepinecarboxamidderivate, verfahren zu ihrer herstellung ,ihre verwendung als arzneimittel, pharmazeutische zubereitungen und ihre verwendung | |
| IE890145L (en) | PROCESS FOR THE PREPARATION OF 3-(3-PYRIDYL)-1H,¹3H-PYRROLO£1,2-c|THIAZOLE-7-CARBONITRILE | |
| TW343973B (en) | Morphinan derivative and medical use | |
| MX9803556A (es) | Derivados de aminoacidos, medicamentos que contienen tales compuestos y metodos para producirlos. | |
| EP0596113A4 (en) | Method of decomposing polyamide. | |
| KR910009258A (ko) | 니트록시닐과 레바미솔 복합주사제의 제조방법 | |
| HUP0001520A2 (hu) | Javított eljárás optikailag aktív O,O'-dibenzoil-borkősavak és optikailag aktív O,O'-di(p-toluoil)-borkősavak anhidridjeinek előállítására |